<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="31530">Edaravone</z:chebi> (MCI-186) is a potent free radical scavenger used clinically to treat <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Its <z:chebi fb="11" ids="22586">antioxidant</z:chebi> ability maybe also do favor to protect against lung injury </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, we evaluated whether <z:chebi fb="0" ids="31530">edaravone</z:chebi> could protect against lung injury and <z:hpo ids='HP_0002206'>pulmonary fibrosis</z:hpo> in <z:chebi fb="11" ids="34905">paraquat</z:chebi>-treated rats </plain></SENT>
<SENT sid="3" pm="."><plain>Rats were divided into four groups (Control group, <z:chebi fb="0" ids="31530">Edaravone</z:chebi> group, <z:chebi fb="11" ids="34905">Paraquat</z:chebi> intoxication group and <z:chebi fb="11" ids="34905">Paraquat</z:chebi>+<z:chebi fb="0" ids="31530">Edaravone</z:chebi> group) and sacrificed on day 1, 3, 5, 7, 14 and 28 </plain></SENT>
<SENT sid="4" pm="."><plain>Lung tissue and bronchoalveolar lavage fluid (BALF) were collected and analyzed biochemically and histologically </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="11" ids="34905">Paraquat</z:chebi> intoxication significantly increased malondialdehyde (<z:chebi fb="14" ids="32506">MDA</z:chebi>), hydroproline, interleukin-6 (IL-6) and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-α (TNF-α) levels in lung tissue and BALF, and also increased <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression of transforming growth factor-β1 (TGF-β1), matrix metalloproteinase-2 (MMP-2), and tissue inhibitor of metalloproteinase-1 (TIMP-1) in lung tissue, but decreased SOD and GSH-PX activity in lung tissue and BALF </plain></SENT>
<SENT sid="6" pm="."><plain>Histological examination of <z:chebi fb="11" ids="34905">paraquat</z:chebi>-treated rats showed <z:hpo ids='HP_0011009'>acute</z:hpo> injury with interstitial <z:hpo ids='HP_0000969'>edema</z:hpo> and widespread inflammatory cell infiltration in the alveolar space and septum, as well as <z:mp ids='MP_0003045'>fibrosis</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>After <z:chebi fb="0" ids="31530">edaravone</z:chebi> treatment, levels of <z:chebi fb="14" ids="32506">MDA</z:chebi>, IL-6, TNF-α and hydroproline decreased, but SOD and GSH-PX activity in lung tissue and BALF increased </plain></SENT>
<SENT sid="8" pm="."><plain>In addition, the <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression of TGF-β1, MMP-2, and TIMP-1 down-regulated </plain></SENT>
<SENT sid="9" pm="."><plain>Histological examination showed that <z:chebi fb="0" ids="31530">edaravone</z:chebi> decreased interstitial <z:hpo ids='HP_0000969'>edema</z:hpo>, inflammatory cell infiltration and prevented the process of <z:hpo ids='HP_0002206'>pulmonary fibrosis</z:hpo> </plain></SENT>
</text></document>